NVS

Novartis AG

HealthcareDrug Manufacturers - GeneralCHUSDPeers →Country macro →

$150.88

-0.36%LiveJun 17, 2026

AI Brief

Market cap

$287.89B

52w range

112.34 – 170.46

P / E

—

EPS

—

Volume

1.57M

Revenue · FY

—

Overview Fundamentals Market Narrative & AI

Prices Trend Earnings Call language

Explain this page

Arphra AIPlain-English read on Novartis AG’s valuation

Next report

upcoming

No forward estimate on file.

Beat streak

consecutive EPS beats

Avg surprise

—

trailing 0q

EPS · actual vs estimate

· earnings_history

actualestimate

No earnings history on file.

Forward consensus

No forward annual estimates on file.

Revenue · actual vs estimate ($B)

No revenue estimate history on file.

Reports tracked

Beat rate

—

0 beats · 0 misses (last 12)

Next report

—

Last report

—

Earnings call transcripts

DB24

Period	Date	Words	Excerpt
FY2025 Q4	Feb 04, 2026	11,680	Operator: Good morning and good afternoon, and welcome to the Novartis Q4 Full Year 2025 Results Release Conference Call and Live Webcast. [Operator Instructions] The conference is being recorded. A r	Read →
FY2025 Q3	Oct 28, 2025	10,948	Operator: Good morning and good afternoon, and welcome to the Novartis Q3 2025 Results Release Conference Call and Live Webcast. [Operator Instructions] The conference is being recorded. [Operator Ins	Read →
FY2025 Q2	Jul 21, 2025	12,273	Operator: Good morning and good afternoon, and welcome to the Novartis Q2 2025 Results Release Conference Call and Live Webcast. [Operator Instructions]. The conference is being recorded. [Operator In	Read →
FY2025 Q1	Apr 29, 2025	10,780	Operator: Good morning and good afternoon, and welcome to the Novartis Q1 2025 Results Release Conference Call and Live Webcast. [Operator Instructions] A recording of the conference call, including t	Read →
FY2024 Q4	Jan 31, 2025	10,491	Operator: Good morning and good afternoon, and welcome to the Novartis Q4 2024 Results Release Conference Call and Live Webcast. [Operator Instructions] A recording of the conference call, including t	Read →
FY2024 Q3	Oct 29, 2024	10,648	Operator: Good morning and good afternoon, and welcome to the Novartis Q3 2024 Results Release Conference Call and Live Webcast. Please note that during the presentation all participants will be in a	Read →
FY2024 Q2	Jul 18, 2024	11,680	Operator: Good morning and good afternoon, and welcome to the Novartis Q2 2024 Results Release Conference Call and Live Webcast. Please note that during the presentation all participants will be in a	Read →
FY2024 Q1	Apr 23, 2024	10,238	Operator: Good morning and good afternoon, and welcome to the Novartis Q1 2024 Results Release Conference Call and Live Webcast. Please note that during the presentation, all participants will be in a	Read →
FY2023 Q4	Jan 31, 2024	11,600	Operator: Good morning, and good afternoon, and welcome to the Novartis Q4 2023 Results Release Conference Call and Live Webcast. Please note, that during the presentation all participants will be in	Read →
FY2023 Q3	Oct 24, 2023	11,585	Operator: Good morning, and good afternoon, and welcome to the Novartis Q3 2023 Results Release Conference Call and Live Webcast. Please note that during the presentation, all participants will be in	Read →
FY2023 Q2	Jul 18, 2023	11,206	Operator: Good morning and good afternoon, and welcome to the Novartis Q2 2023 Results Release Conference Call and Live Webcast. [Operator Instructions] And the conference is being recorded. [Operator	Read →
FY2023 Q1	Apr 25, 2023	11,678	Operator: Good morning and good afternoon, and welcome to the Novartis Q1 2023 Results Release Conference Call and Live Webcast. [Operator Instructions] And the conference is being recorded. [Operator	Read →
FY2022 Q4	Feb 01, 2023	13,942	Operator: Good morning and good afternoon, and welcome to the Novartis Q4 2022 Results Release Conference Call and Live Webcast. Please note that during the presentation all participants will be in a	Read →
FY2022 Q3	Oct 25, 2022	14,109	Operator: Good morning and good afternoon and welcome to the Novartis Q3 2022 Results Release Conference Call and Live Webcast. [Operator Instructions] A recording of the conference call, including th	Read →
FY2022 Q2	Jul 19, 2022	13,435	Operator: Good morning and good afternoon, and welcome to the Novartis Q2 2022 Results Release Conference Call and Live Webcast. Please note that during the presentation, all participants will be a li	Read →
FY2022 Q1	Apr 26, 2022	13,882	Operator: Good morning and good afternoon. And welcome to the Novartis Q1 2022 Results Release Conference Call and Live Webcast. Please note that during the presentation, all participants will be a li	Read →
FY2021 Q4	Feb 02, 2022	13,807	Operator: Good morning and good afternoon. And welcome to the Novartis Q4 and Full Year 2021 Results Release Conference Call and Live Webcast. [Operator Instructions]. With that, I would like to hand	Read →
FY2021 Q3	Oct 26, 2021	13,987	Operator: Good morning and good afternoon, and welcome to the Novartis Q3, 2021 results release, conference call, and live webcast. Please note that during the presentation, all participants will be i	Read →
FY2021 Q2	Jul 21, 2021	14,974	Operator: Good morning and good afternoon, and welcome to the Novartis' Q2 2021 Results Release Conference Call and Live Webcast. Please note that during the presentation all participants will be in a	Read →
FY2021 Q1	Apr 27, 2021	13,182	Samir Shah: Thank you very much. And good morning and good afternoon everybody. Thank you for taking the time to join us on the Q1 Results Conference Call. We appreciate that you are taking the time.	Read →
FY2020 Q4	Jan 26, 2021	14,689	Samir Shah: Thanks and good morning and good afternoon to everybody and thank you for taking the time to join us on this Q4 and Full Year Results Presentation. The information presented today contains	Read →
FY2020 Q3	Oct 27, 2020	14,090	Disclaimer: NEW We are providing this transcript version in a raw, machine-assisted format and it is unaudited. Please reference the audio for any questions on the content. A standard transcript wil	Read →
FY2020 Q2	Jul 21, 2020	14,408	Operator: Good morning, good afternoon, and welcome to the Novartis Q2 2020 Results Release Conference Call and Live Audio Webcast. Please note that during the presentation, all participants will be i	Read →
FY2020 Q1	Apr 28, 2020	14,494	Operator: Good morning, and good afternoon, and welcome to the Novartis Q1 2020 Results Release Conference Call and Live Audio Webcast. [Operator Instructions]. With that, I would like to hand over t	Read →

Click Read → for the full transcript with keyword cloud and on-demand AI analyst summary.

Earnings surprises · history

DB · earnings_surprises50% beat2

Period end	Estimate EPS	Actual EPS	Surprise %	Outcome
Apr 28, 2026	$2.11	$1.99	-5.69%	Miss
Feb 04, 2026	$1.99	$2.03	+2.01%	Beat

Earnings history

Date	EPS · est	EPS · actual	Surprise	Revenue · est	Revenue · actual	Result
No earnings history available.

Analyst estimates · annual

Period	EPS · avg	Revenue · avg	# Analysts
No analyst estimates returned.

Analyst estimates · quarterly

Period	EPS · avg	Revenue · avg	# Analysts
No analyst estimates returned.